Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Bioburden Method Suitability for Cleaning and Sanitation Monitoring: How Far Do We Have to Go?
The author reviews test methods for microbiological cleaning processes and suggests ways to improve microbial bioburden method suitability studies.


Pharmaceutical Technology
Volume 34, Issue 8

References

1. R.L. Dyer et al., "Microbiological Tests for Equipment, Containers, Water and Air" in Standard Methods for the Examination of Dairy Products, R.T. Marshall, Ed. 17th ed. (American Public Health Association, Washington, USA, 17th ed., 2004), pp. 328.

2. R. Angelotti et al., Health. Lab. Sci. 1, 289–96 (1964).

3. J.M. Barnes, Proc. Soc. Appl. Bacteriol., 15, 34–40 (1952).

4. G.S. Brown et al., J. of Appl. Microbiol. 103 (4), 1074–1080 (2007).

5. M.S. Favero et al., J. Appl. Bacteriol., 31 (3), 336–43 (1968).

6. L.B. Rose et al., Emerg. Infect. Diseas., 10 (6),1023–1029 (2004).

7. A. Niskanen and M.S. Pohja, J. of Appl. Bacteriol. 42, 53–63 (1977).

8. V. Marshall, S. Poulson-Cook, and J. Moldenhauer, PDA J. Pharm. Sci Technol. 52 (4), 165–169 (1998).

9. S.A. Salo et al., J. of AOAC Intl. 83, 1357–1365 (2000).

10. D. Kang et al., J. of AOAC Intl. 90 (3), 810–816 (2007).

11. J.F. Frank, "Microbial attachment to food and food contact surfaces" in "Advances in Food and Nutrition Research," Taylor, S.L., Ed. (CA. Academic Press, San Diego, Vol. 43, 2001) pp. 320–370.

12. G. Moore and C. Griffith, Dairy, Food, and Environmental Sanitation 22 (6), 410–421 (2002a).

13. G. Moore and C. Griffith, Food Microbiol. 19, 65–73 (2002b).

14. J.W. Costerton et al., Annu. Rev. Microbiol. 49, 711–745 (1995).

15. H.D. Kusumaningrum et al., Intl. J. of Food Microbiol. 85 (3), 227–236 (2003).

16. PDA Technical Report No. 29, "Points to Consider for Cleaning Validation," PDA J. Pharm.Sci. and Tech., 52 (6), 1–23 (1998).

17. FDA, Guide to Inspections of Validation of Cleaning Processes, (Rockville, MD, July 1993).

18. P. Tandon, S. Chhibber, and R.H. Reed, J. of Gen. and Mol. Microbiol., 88 (1), 35–48 (2005).

19. A.P. Williams et al., J. of Appl. Microbiol. 98 (5), 1075–1083 (2005).

20. A.A. Mafu et al., J. of Food Protection, 53 (9), 742–746 (1990).

21. L. B. Rose et al., Emerg. Infect. Diseas., 10 (6), 1023–1029 (2004).

22. D.R. Absolom et al., Appl. and Env. Microbiol., 46 (1), 90–97 (1983).

23. L.O. Egwari, and M.A. Taiwo, West Indian Med. J. 53 (3), 164–169 (2004).

24. H.H.M. Rijnaarts et al., Environ. Sci. Technol. 30 (10), 2877–2883 (1996).

25. W. Lynch, Handbook of Silicone Rubber Fabrication, (Van Nostrand Reinhold, New York, 1978).

26. X. Xie et al., Appl. Microbiol. and Biotech. 73 (3), (2006).

27. G.M. Chudzik, J. Validation Technol. 5 (1), 77–81 (1998).

28. J. Kahovec, R.B. Fox, and K. Hatada, Pure and Applied Chem. 74 (10), 1921–1956 (2002).

29. A.N. Neely and M.P. Maley, J. of Clinic Microbiol., 38 (2), 724–726 (2000).

30. A.N. Neely and M.P. Maley, Am. J. of Infect. Cont. 29 (2), 131–132 (2001).

31. Y. Endo, T. Tani, and M. Kodama, Appl. Environ. Microbiol. 53 (9), 2050–2055 (1987).

32. S. Fidai, S.W. Farer, and R.E. Hancock, Methods Mol. Biol. 78, 187–204 (1997).

33. S.J. Kim, Marine Ecology – Progress Series 26, 203–206 (1985).

34. J.C. Tiller et al., Proc. Natl. Acad. Sci. USA 98 (11), 5981–5985 (2001).

35. G. Reiser, Using Technology to Break the Contamination Chain, Business Briefing: Hospital Engineering and Facilities Management, Issue No. 2 (2005).

36. A. Winn, Medical Plastics and Biomaterials 3 (2), 16–19 (1996).

37. E. Robine, D. Derangere, and D. Robin, Inter. J. of Food Microbiol. 55 (1–3), 229–234 (2000).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here